GoodRx logo

GoodRx

GDRX | NASDAQ
Chart Builder DCF Calculator
$3.51
-$0.05 (-1.40%)
At close: Nov 16, 2026, 4:00 PM ET
$3.51
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.40%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
38.7
Fundamentals Weak
Market Sentiment Bullish
Moat Narrow
Sector Rank #559/1021 (Top 55%)

Key Statistics

Market Data

Market Cap $1.2B
1D Range
3.48 3.60
52W Range
1.87 3.80

Valuation (TTM)

PE 82.59
PB 1.85
EV/EBITDA 8.43

Valuation (NTM)

Forward PE 11.87
Forward PEG -3.98
Price Target $4.00
Loading financial charts...

Profile

GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform...

Sector Healthcare
Employees 697
IPO Date Sep 23, 2020
Fiscal Year January - December

Latest News

GoodRx Brings Prescription Pricing Intelligence to Google Cloud's Gemini for Healthcare

6 days ago · businesswire.com

GoodRx Brings Prescription Pricing Intelligence to Google Cloud's Gemini for Healthcare
GoodRx Holdings Is Going Through A Painful Transition That Will Pay Off

17 days ago · seekingalpha.com

GoodRx Holdings Is Going Through A Painful Transition That Will Pay Off
Amazon, GoodRx target US prescription subscribers as health insurance coverage slips

2 months ago · reuters.com

Amazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx Covers Whole Households and Pets in New Prescription Plan

2 months ago · pymnts.com

GoodRx Covers Whole Households and Pets in New Prescription Plan
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope

3 months ago · seekingalpha.com

GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

3 months ago · seekingalpha.com

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
GoodRx Q2 Earnings Call Highlights

3 months ago · marketbeat.com

GoodRx Q2 Earnings Call Highlights
GoodRx and Oscar Health Tout Tech as Consumer Needs Change

3 months ago · pymnts.com

GoodRx and Oscar Health Tout Tech as Consumer Needs Change
GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

3 months ago · zacks.com

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

3 months ago · zacks.com

GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Earnings

Next Earnings
Nov 17, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
10
Consensus
Hold
Price Target
$4.00
Upside
+13.96%
Buy (3)
Hold (6)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.